Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
August 13, 2021
Author Correction: Telomere-to-telomere assembled and centromere annotated genomes of the two main subspecies of the button mushroom Agaricus bisporus reveal especially polymorphic chromosome ends
Anton S M Sonnenberg, Narges Sedaghat-Telgerd, Brian Lavrijssen, et al.
Scientific Reports
|
September 5, 2020
Telomere-to-telomere assembled and centromere annotated genomes of the two main subspecies of the button mushroom Agaricus bisporus reveal especially polymorphic chromosome ends
Anton S M Sonnenberg, Narges Sedaghat-Telgerd, Brian Lavrijssen, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
M L Huang, A Van Peer, R Woestenborghs, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations
E Snoeck, V Piotrovskij, P Jacqmin, et al.
Clinical Pharmacy
|
August 1, 1987
Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent
J A Barone, Y C Huang, R H Bierman, et al.
British Journal of Clinical Pharmacology
|
November 1, 1996
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine
E Snoeck, P Jacqmin, A Van Peer, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 20, 1990
New non-steroidal aromatase inhibitors: focus on R76713
R De Coster, W Wouters, C R Bowden, et al.
Clinical Therapeutics
|
January 28, 1998
Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke
J De Keyser, V Van de Velde, R L Schellens, et al.
British Journal of Clinical Pharmacology
|
June 1, 1997
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates
E Snoeck, V Piotrovskij, P Jacqmin, et al.
Molecular Pharmaceutics
|
February 15, 2017
In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context
H Lennernäs, A Lindahl, A Van Peer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
August 13, 2021
Author Correction: Telomere-to-telomere assembled and centromere annotated genomes of the two main subspecies of the button mushroom Agaricus bisporus reveal especially polymorphic chromosome ends
Anton S M Sonnenberg, Narges Sedaghat-Telgerd, Brian Lavrijssen, et al.
Scientific Reports
|
September 5, 2020
Telomere-to-telomere assembled and centromere annotated genomes of the two main subspecies of the button mushroom Agaricus bisporus reveal especially polymorphic chromosome ends
Anton S M Sonnenberg, Narges Sedaghat-Telgerd, Brian Lavrijssen, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
M L Huang, A Van Peer, R Woestenborghs, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations
E Snoeck, V Piotrovskij, P Jacqmin, et al.
Clinical Pharmacy
|
August 1, 1987
Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent
J A Barone, Y C Huang, R H Bierman, et al.
British Journal of Clinical Pharmacology
|
November 1, 1996
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine
E Snoeck, P Jacqmin, A Van Peer, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 20, 1990
New non-steroidal aromatase inhibitors: focus on R76713
R De Coster, W Wouters, C R Bowden, et al.
Clinical Therapeutics
|
January 28, 1998
Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke
J De Keyser, V Van de Velde, R L Schellens, et al.
British Journal of Clinical Pharmacology
|
June 1, 1997
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates
E Snoeck, V Piotrovskij, P Jacqmin, et al.
Molecular Pharmaceutics
|
February 15, 2017
In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context
H Lennernäs, A Lindahl, A Van Peer, et al.
Page
of 7